{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:37:42Z","timestamp":1792841862691,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001061","name":"Rebecca L Cooper Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.rbmo.2026.105885","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:02:42Z","timestamp":1784908962000},"page":"105885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["BRCA1 deficiency in oocytes compromises ovulation without exacerbating follicle loss after chemotherapy in mice"],"prefix":"10.1016","volume":"53","author":[{"given":"Yujie","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren R.","family":"Alesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Stringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeen","family":"Zerafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Rainczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Winship","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla J.","family":"Hutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2026.105885_bib0001","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ygyno.2011.08.032","article-title":"A high response rate to liposomal doxorubicin is seen among women with BRCA mutations treated for recurrent epithelial ovarian cancer","volume":"123","author":"Adams","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.rbmo.2026.105885_bib0002","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/molehr\/gaz055","article-title":"The spatio-temporal dynamics of mitochondrial membrane potential during oocyte maturation","volume":"25","author":"Al-Zubaidi","year":"2019","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.rbmo.2026.105885_bib0003","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.coemr.2020.12.004","article-title":"Evaluating the impacts of emerging cancer therapies on ovarian function","volume":"18","author":"Alesi","year":"2021","journal-title":"Current Opinion in Endocrine and Metabolic Research"},{"key":"10.1016\/j.rbmo.2026.105885_bib0004","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ejca.2020.11.032","article-title":"Cancer survivorship: Reproductive health outcomes should be included in standard toxicity assessments","volume":"144","author":"Anderson","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.rbmo.2026.105885_bib0005","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2217\/fon-2016-0176","article-title":"Chemotherapy-induced damage to ovary: mechanisms and clinical impact","volume":"12","author":"Bedoschi","year":"2016","journal-title":"Future Oncol"},{"key":"10.1016\/j.rbmo.2026.105885_bib0006","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41419-019-1961-y","article-title":"Kinase-independent inhibition of cyclophosphamide-induced pathways protects the ovarian reserve and prolongs fertility","volume":"10","author":"Bellusci","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.rbmo.2026.105885_bib0007","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1477-7827-8-20","article-title":"Doxorubicin-induced ovarian toxicity","volume":"8","author":"BEN-AHARON","year":"2010","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.rbmo.2026.105885_bib0008","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.rbmo.2026.105885_bib0009","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of Multidrug Resistance in Cancer Chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rbmo.2026.105885_bib0010","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s10897-016-0035-x","article-title":"Reproductive Decision-Making in Women with BRCA1\/2 Mutations","volume":"26","author":"Chan","year":"2017","journal-title":"J Genet Couns"},{"key":"10.1016\/j.rbmo.2026.105885_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2014.10.008","article-title":"Beyond BRCA: new hereditary breast cancer susceptibility genes","volume":"41","author":"Economopoulou","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.rbmo.2026.105885_bib0012","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","article-title":"Cyclophosphamide and cancer: golden anniversary","volume":"6","author":"Emadi","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.rbmo.2026.105885_bib0013","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/humrep\/dew027","article-title":"ESHRE Guideline: management of women with premature ovarian insufficiency","volume":"31","author":"Webber","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2026.105885_bib0014","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1073\/pnas.1617233114","article-title":"mTORC1\/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy","volume":"114","author":"Goldman","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rbmo.2026.105885_bib0015","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0015-0282(01)01959-8","article-title":"Effect of paclitaxel on primordial follicular reserve in mice","volume":"76","author":"Gucer","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2026.105885_bib0016","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1021\/cr980421n","article-title":"Structure, Recognition, and Processing of Cisplatin-DNA Adducts","volume":"99","author":"Jamieson","year":"1999","journal-title":"Chem Rev"},{"key":"10.1016\/j.rbmo.2026.105885_bib0017","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005402","article-title":"Cyclophosphamide Triggers Follicle Activation and \u201cBurnout\u201d; AS101 Prevents Follicle Loss and Preserves Fertility","volume":"5","author":"KALICH-PHILOSOPH","year":"2013","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.rbmo.2026.105885_bib0018","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.fertnstert.2025.08.017","article-title":"Fertility preservation for cancer: referral guidelines, treatment options, and specific considerations","volume":"124","author":"Kalluru","year":"2025","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2026.105885_bib0019","doi-asserted-by":"crossref","first-page":"E1688","DOI":"10.1073\/pnas.1620729114","article-title":"AMH\/MIS as a contraceptive that protects the ovarian reserve during chemotherapy","volume":"114","author":"Kano","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rbmo.2026.105885_bib0020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1530\/REP-11-0430","article-title":"The primordial follicle reserve is not renewed after chemical or gamma-irradiation mediated depletion","volume":"143","author":"Kerr","year":"2012","journal-title":"Reproduction"},{"key":"10.1016\/j.rbmo.2026.105885_bib0021","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.rbmo.2026.105885_bib0022","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1016\/j.febslet.2010.07.029","article-title":"The MRN complex in double-strand break repair and telomere maintenance","volume":"584","author":"Lamarche","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.rbmo.2026.105885_bib0023","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ctrv.2017.07.001","article-title":"Fertility and pregnancy issues in BRCA-mutated breast cancer patients","volume":"59","author":"Lambertini","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.rbmo.2026.105885_bib0024","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/annonc\/mdx639","article-title":"Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients","volume":"29","author":"Lambertini","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.rbmo.2026.105885_bib0025","first-page":"4355","article-title":"Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase","volume":"54","author":"Long","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.rbmo.2026.105885_bib0026","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1101\/gad.11.10.1226","article-title":"Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1\/Brca2, Brca1\/p53, and Brca2\/p53 nullizygous embryos","volume":"11","author":"Ludwig","year":"1997","journal-title":"Genes Dev"},{"key":"10.1016\/j.rbmo.2026.105885_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105386","article-title":"Paclitaxel is evidence to reduce growing ovarian follicle growth in mice model study","volume":"83","author":"Maidarti","year":"2022","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.rbmo.2026.105885_bib0028","first-page":"103","article-title":"Taxol (paclitaxel) was approved by FDA for the treatment of patients with recurrent ovarian cancer","volume":"54","author":"Menzin","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.rbmo.2026.105885_bib0029","series-title":"Australian Code for Responsible Conduct of Research [Online]","year":"2018"},{"key":"10.1016\/j.rbmo.2026.105885_bib0030","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nm.4118","article-title":"RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers","volume":"22","author":"Nolan","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.rbmo.2026.105885_bib0031","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/s41598-022-05357-x","article-title":"Ovarian toxicity of carboplatin and paclitaxel in mouse carriers of mutation in BRIP1 tumor suppressor gene","volume":"12","author":"Ntemou","year":"2022","journal-title":"Scientific Reports"},{"key":"10.1016\/j.rbmo.2026.105885_bib0032","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.annonc.2020.03.284","article-title":"ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)","volume":"31","author":"PALUCH-SHIMON","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.rbmo.2026.105885_bib0033","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/humrep\/dev271","article-title":"Lifestyle factors associated with histologically derived human ovarian non-growing follicle count in reproductive age women","volume":"31","author":"Peck","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2026.105885_bib0034","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/23809000.2016.1139458","article-title":"Chemotherapy-induced premature ovarian failure and its prevention in premenopausal breast cancer patients","volume":"1","author":"Poggio","year":"2016","journal-title":"Expert Review of Quality of Life in Cancer Care"},{"key":"10.1016\/j.rbmo.2026.105885_bib0035","article-title":"Update on Adjuvant Chemotherapy for Early Breast Cancer","volume":"8","author":"Rampurwala","year":"2014","journal-title":"Breast Cancer: Basic and Clinical Research"},{"key":"10.1016\/j.rbmo.2026.105885_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108174","article-title":"Bortezomib prevents acute doxorubicin ovarian insult and follicle demise, improving the fertility window and pup birth weight in mice","volume":"9","author":"Roti Roti","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.rbmo.2026.105885_bib0037","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13048-020-00724-6","article-title":"Comparison of methods for quantifying primordial follicles in the mouse ovary","volume":"13","author":"Sarma","year":"2020","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.rbmo.2026.105885_bib0038","doi-asserted-by":"crossref","first-page":"782","DOI":"10.18632\/aging.100363","article-title":"Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise","volume":"3","author":"Soleimani","year":"2011","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.rbmo.2026.105885_bib0039","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1126\/science.6093249","article-title":"Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II","volume":"226","author":"Tewey","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.rbmo.2026.105885_bib0040","doi-asserted-by":"crossref","first-page":"172ra21","DOI":"10.1126\/scitranslmed.3004925","article-title":"Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans","volume":"5","author":"Titus","year":"2013","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.rbmo.2026.105885_bib0041","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/humupd\/dmz043","article-title":"BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging","volume":"26","author":"Turan","year":"2020","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.rbmo.2026.105885_bib0042","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1200\/JCO.20.02880","article-title":"Association of Germline BRCA Pathogenic Variants With Diminished Ovarian Reserve: A Meta-Analysis of Individual Patient-Level Data","volume":"39","author":"Turan","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rbmo.2026.105885_bib0043","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/molehr\/gah015","article-title":"Anti-M\u00fcllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment","volume":"10","author":"Weenen","year":"2004","journal-title":"Molecular Human Reproduction"},{"key":"10.1016\/j.rbmo.2026.105885_bib0044","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/humupd\/dmy002","article-title":"The importance of DNA repair for maintaining oocyte quality in response to anti-cancer treatments, environmental toxins and maternal ageing","volume":"24","author":"Winship","year":"2018","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.rbmo.2026.105885_bib0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033810","article-title":"Do BRCA1 and BRCA2 gene mutation carriers have a reduced ovarian reserve? Protocol for a prospective observational study","volume":"9","author":"Winship","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.rbmo.2026.105885_bib0046","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1093\/humrep\/deaa128","article-title":"The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation","volume":"35","author":"Winship","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2026.105885_bib0047","first-page":"164","article-title":"Accurate Follicle Enumeration in Adult Mouse Ovaries","author":"Winship","year":"2020","journal-title":"J Vis Exp."},{"key":"10.1016\/j.rbmo.2026.105885_bib0048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43018-022-00413-x","article-title":"Checkpoint inhibitor immunotherapy diminishes oocyte number and quality in mice","volume":"3","author":"Winship","year":"2022","journal-title":"Nat Cancer"},{"key":"10.1016\/j.rbmo.2026.105885_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105262","article-title":"Conditional loss of Brca1 in oocytes causes reduced litter size, ovarian reserve depletion and impaired oocyte in vitro maturation with advanced reproductive age in mice","volume":"106","author":"Winship","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.rbmo.2026.105885_bib0050","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/hmg\/ddt486","article-title":"Two classes of ovarian primordial follicles exhibit distinct developmental dynamics and physiological functions","volume":"23","author":"Zheng","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.rbmo.2026.105885_bib0051","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.fertnstert.2022.01.016","article-title":"Long-term antim\u00fcllerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors","volume":"117","author":"Zhou","year":"2022","journal-title":"Fertility and Sterility"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648326004268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648326004268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:04:35Z","timestamp":1792839875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648326004268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1472648326004268"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2026.105885","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BRCA1 deficiency in oocytes compromises ovulation without exacerbating follicle loss after chemotherapy in mice","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2026.105885","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of Reproductive Healthcare Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105885"}}